Author
Year
No. of subjects
Age of subjects (years)
White matter:
location (% reduction)
Total:
area (% reduction)
Pakkenberg and Gundersen [166]
1997
94
20–95
Cerebral hemispheres
(28 %)
Cerebral hemispheres
(12 %)
Tang et al. [167]
1997
Length of fibers in cerebral hemisphere
(27 %)
Marner et al. [168]
2003
26
20–80
Cerebral hemispheres
(23 %)
Overall nerve fiber length
(45 %)
Meier-Ruge et al. [169]
1992
Precentral gyrus
(16 %)
Corpus callosum
(10.5 %)
Traumatic brain injury in the elderly contributes to the cellular loss in the natural aging process and may further enhance any pathological diseases in these patients. Immediate cell death in the brain following traumatic brain injury is dependent upon the type of injury. For example, a penetrating injury or localized impact initially causes focal damage, whereas a rotational head injury or larger impact may cause diffuse brain injury. When mechanical damage occurs, it has been shown that axonal damage can be primary from direct injury or secondary from death following initial swelling [69, 70]. In either case, axonal injury leads to cell death and eventually to coma and increased mortality [71].
Another main mechanism of primary injury in traumatic brain injury results from direct damage to blood vessels in the context of naturally changing and weaker vasculature. Geriatric patients are more susceptible to immediate vascular damage. Due to the decreased volume associated with age and decreased neuronal density, the brains of elderly patients allow for more space in which the subdural veins are located [26, 36, 71]. As such, they are less protected and more prone to rupture causing a subdural hematoma. Additionally, the inherent strength of the cellular composition of blood vessels with age is diminished, increasing the incidence of leakage and rupture following less intense mechanical disruptions that might cause hemorrhage in younger patients.
Another important aspect of vascular changes with increased age is a natural decrease in cerebral blood flow (CBF) and altered vascular reactivity [72–75]. Studies suggest the decreased intracranial blood flow with age is associated with arteriolar rarefaction, with conflicting evidence regarding capillary density [73–76]. A combination of factors is most likely responsible from hormonal to structural changes of the vessels in addition to changes in blood flow decreases metabolism and affects signaling, neuronal plasticity, and neurogenesis [76]. Decreased CBF with age and following injury leads to hypoxia and further damage. A study in rats following fluid-percussion injury showed decreased heart rate in aged subjects while increased heart rate in the younger rats. The aged rats showed significantly increased damage using histopathology and mortality end points [77]. Although autoregulation is not markedly diminished in the normal aging process [78–81], studies have shown decreased autoregulation associated with traumatic brain injury [82–84]. This change in vascular reactivity results in worse outcomes following traumatic brain injury [84].
Secondary Changes
Mechanical perturbation from direct injury results in the release of ions, toxins, and neurotransmitters. Damaged cells experience metabolic changes which contribute to the toxic metabolites, namely, lactate, in the microenvironment of the injured brain tissue. Both mechanisms further contribute to secondary cellular loss and subsequent injury mechanisms, such as edema and inflammation, in the aging brain.
One of the first ions to be released following increased membrane permeability or cell death is intracellular calcium [85]. The significance of calcium release is to set in motion the prolonged apoptotic and immediate necrotic pathways via caspase and calpain proteases, respectively [86–88]. Another ion released in secondary brain injury is magnesium, an indicator of cell injury [89–92].
Glutamate is the main excitatory neurotransmitter in the central nervous system as well as the main neurotransmitter responsible for increased damage following TBI in geriatric patients [86, 93, 94]. Hamm et al. suggest this effect is particularly harmful in an aged brain due to the increased density of receptors with age due to a natural loss of neurons. The additional overstimulation may contribute to the injury in an aged brain [78]. Lactate is also released into the microenvironment and increasingly taken up by the brain following traumatic injury [89, 95–106]. The increased concentrations of lactate can lead to edema via breakdown of the blood-brain barrier [89, 107–110], or ischemia [89–111]. The reason for increased production and utilization of lactate remains unclear; however, one study has linked increased lactate uptake by the brain with improved outcomes [106].
Numerous studies have concluded that the formation of free radicals [86, 112, 113] contributes to secondary cell damage and death following TBI. The pertinent free radicals in this context include superoxide anion (O2−), nitric oxide (NO), and peroxynitrite (ONOO−). These substances are formed immediately following the rise in extracellular calcium ions [113], as well as in response to altered neuronal metabolism, vascular changes, and the other mechanisms of secondary injury following TBI [112, 114]. Free radicals increase the damage following TBI by interfering with vasodilation [115] and subcellular components [116, 117], in addition to creating oxidative stress [117].
Decreased blood flow, local toxins, and altered metabolism contribute to hypoxia and ischemia of brain tissue following TBI in geriatric patients. Neuronal and glial cell death adds to the normal aging degeneration of these cells because there is increased susceptibility [118, 119].
Another mechanism of secondary injury following TBI is the resulting inflammation and edema of brain tissue [120]. In addition to hemorrhage, inflammation and edema contribute to increased intracranial pressure (ICP). The decreased ability of the aged brain to compensate for the changes in volume may be another reason for the increased morbidity and mortality in this patient population. Evidence suggests inflammation results from the release of pro-inflammatory cytokines and mediators [121, 122]. Onyszchuk et al. reported the edema that results in young and aged rats yet, in the latter, requires a longer period of time to subside and involves a larger area of the brain [118].
Lastly, studies have reported the formation of thrombin following TBI [123, 124]. This coagulation mediator becomes particularly important in a patient population that is frequently prescribed anticoagulation therapy for atrial fibrillation, ischemic heart disease, and peripheral vascular disease. One study showed the injection of thrombin into the caudate of mice correlated with increased infiltration of inflammatory cells, angiogenesis, and reactive gliosis. In effect, this mediator that is released following trauma contributes to the inflammatory response [125].
Structural Injury
In a geriatric patient, brain injury does not require impact, for damage can result merely from deceleration or rotation of the head [6]. The most common manifestation following TBI in elderly patients are subdural hematomas, which may be of an acute or chronic nature. One study showed that in ≥70 years old, 61 % subdural, 28 % intracerebral, and 4 % epidural occurred compared to 47 % of epidural or subdural hematomas among ages 6–39 [3]. Subdural hematomas are more common than extradural hematomas after 50 years old [4, 126].
Contusions occur at approximately the same rate in patients suffering TBI and will significantly enlarge in approximately one-third. This worsening, however, may occur at a higher rate in the anticoagulated elderly.
Intracerebral hematomas occur at a higher rate in the elderly, presumably related to the decreased blood vessel elasticity associated with atherosclerosis [127].
Treatment/Outcomes
Although overwhelming evidence suggests poorer overall outcomes with increased age following TBI, there is discord about whether this trend is stepwise with an age threshold beyond which outcome is significantly worse versus continuously increasing and whether treatment biases based on age have a significant impact. Studies have shown increased mortality in the geriatric population [3], with up to four to six times higher probability for unfavorable outcomes following TBI [128, 129].
For two decades guidelines for the medical and surgical management of severe TBI have been available with increasing utilization of evidence-based treatments to improve outcomes [131]. However these guidelines do not take into account advanced age and thus may not be universally applicable.
Thomas et al. retrospectively showed hospital and death rates after typically nonfatal TBI to increase within the geriatric age in both men and women [128]. Diminished functioning in all areas, cognitive, motor, and memory, has been reported [4, 130]. One study showed an increased rate of postsurgical infection in patients ≥80 years.
Many studies have been conducted to investigate risk factors for worse outcomes following TBI specific to the geriatric population. It has been shown that gender plays a role; females have poorer outcomes [133–136]. This suggests a possible role of estrogen or progesterone in the reparation process following TBI; however, recent randomized controlled trials did not demonstrate any benefit to the administration of progesterone after severe TBI. The specific type of injury has been shown to be another risk factor, postulated to be due to the increased incidence of intracranial mass lesions, such as non-evacuated hematomas, as opposed to systemic complications [3, 6, 8, 137]. Patients with subdural hematomas have worse outcomes than those with epidural hematomas. In one study of patients who received emergency craniotomy, mortality following subdural versus epidural hematomas was 41 % and 3 %, respectively [138]. It was previously reported that older patients with subdural hematomas who undergo craniotomy have worse outcome than younger patients [129–143], yet more recent studies showed no significant difference between age groups with respect to return to baseline following a craniotomy [132].
Mosenthal et al. studied a group of 235 patients with severe TBI, of which 19 % were >65 years old. Functional outcome was not significantly different for both elderly and younger patients and recommended that aggressive treatment in the elderly is warranted [138].
The mainstay of understanding the pathophysiology and risk factors for worse outcomes in the geriatric population is for optimization with regard to treatment and prevention of TBI. Researchers have identified reasons for the existing worse outcomes in these patients. For instance, older patients do not receive the same intensity of care as younger patients [141]. There is a delay getting geriatric patients to neurosurgical intervention when compared to younger patients with TBI [9, 142]. This suggests that improvements in timing and logistical care within hospitals are the first step toward improving outcomes.
Another area of “treatment” targets the patient before they arrive at the hospital. Given that the most common reason for TBI in these patients is falls, it is imperative to work toward the prevention of falls. One way in which this might be possible is to monitor medications that may contribute to falls [143]. Another way is to emphasize bone health and exercise. If patients have appropriate bone density, fractures might be prevented that lead to falling. Additionally, if a patient does fall, an improved muscular response may prevent head impact or injury.
For those in which prevention is not successful, treatment may not be the same for these patients as in younger patients. It becomes the responsibility of the emergency room physician to know which medications and therapeutic procedures to administer. Additionally, it is the responsibility of the neurosurgeon to know in whom it is appropriate to operate. In one study, indications for surgery included GCS score greater than 8, age greater than 75 years, without papillary dilation and all subdural hematomas [142].
Special Considerations
Unfortunately, the care in this patient population is unique given their medications and comorbidities at the time of brain injury. This complicated medical picture requires more research to improve knowledge regarding how common medications and pathological processes in elderly patients may affect the treatment needed following TBI.
Anticoagulation
Many patients >65 years are on some sort of anticoagulation or antiplatelet medication given the well-known vascular processes that predispose older patients to cardiovascular disease. However, the data on the effect of this therapy and TBI is conflicting. Some studies have shown that anticoagulation therapy has a significant effect on outcome. One study showed increased mortality in those who fall from standing taking warfarin [144]. In a retrospective study of 384 patients 55 years or older, warfarin use before a closed head injury was associated with more severe injuries and increased mortality [146]. Yet, other studies have not been able to show a significant effect of anticoagulation therapy on outcome. Fortuna et al. found no significant effect of clopidogrel, aspirin, or warfarin on outcome in those with blunt head trauma [145]. Another study analyzed three age groups within the geriatric population without taking into account mechanism of head injury with nonsignificant findings between pre-injury warfarin use and poor outcome [146–148].
Peiracci et al. further evaluated this question by retrospectively grouping the geriatric patients with TBI based on warfarin use with INR greater or less than 2 and those who did not take warfarin. The group with an INR greater than 2 showed significant likelihood for a GCS score below 13 and increased mortality. In those with an INR less than 2 and those who did not take warfarin prior to injury, the difference in mortality rates was not significant [148]. This study suggests that TBI might be affected not merely by anticoagulation therapy, but instead by the degree of coagulation at the time of injury.
Additional studies used this data to evaluate the effect anticoagulation should have on current therapy in elderly patients that present with TBI. In anticoagulated, elderly patients who present without neurologic deficit, Reynolds et al. recommend CT within 6 h for patients despite GCS score of 14 or 15, whereas Gittleman et al. suggest emergency CT is not necessary in those with GCS score of 15 [149, 150]. In a small study of four patients with mild TBI and GCS score of 15 at presentation, it was suggested to keep elderly patients for observation for 1–2 days due to the occurrence of delayed acute subdural hematoma. In this study, 1/3 of patients survived surgery, while the remaining patient survived with medical management [151].
With respect to reversal of anticoagulant effect, the mainstay has been fresh frozen plasma; however, this may require a significant fluid load in an elderly patient who may have limited cardiac reserve and precipitate congestive heart failure and pulmonary edema. Thus, there has been increasing utilization of prothrombin complex concentrate (PCC) which contains factors II, VII, IX, and X.
With respect to antiplatelet agents, platelet infusions and DDAVP administration can be highly effective.
In recent years the FDA has approved a number of direct thrombin inhibitors (DTIs) and factor XA inhibitors (FXA) for the prevention of thromboembolic events. These are being increasingly utilized as they require no monitoring of the international normalized ratio (INR).
Unfortunately, with respect to TBI, there is no known agent to reverse their anticoagulant effect.
Dialysis is the only currently known way of eliminating these agents; however, the time necessary to do so is likely incompatible with aggressive surgical management, if appropriate.
FFP will not reverse DTIs; PCC and rVIIa have been used with limited success. Tranexamic acid can inhibit fibrinolysis; however, while there is literature in trauma patients endorsing its use, there is none in TBI.
Statins
Another very common medication used to treat cardiovascular disease in elderly patients is statins for hyperlipidemia. Interestingly, data suggest statin use is beneficial in those recovering from TBI. Statin use in patients without cardiovascular disease showed decrease risk and incidence of in-hospital mortality as well as improved functional 12-month outcome in geriatric patients with TBI [152]. This therapy has been shown also to decrease the cerebral vasospasm that follows subarachnoid hemorrhage in brain injury [153, 154].
Medical Comorbidities
The vast majority of geriatric patients have medical comorbidities which complicate outcomes following TBI [28, 155]. The most common comorbid conditions that have been reported include hypertension, diabetes, cardiac arrhythmias, chronic pulmonary disease, and electrolyte disorders [30].
Any of these conditions and the medications needed to treat them complicates the care of geriatric TBI patients.
As an example, while still controversial, high blood sugars may worsen outcome after TBI.
Thus, many trauma centers are now including an individual highly involved or specialized in geriatric medical care on the trauma team.
Concussion
Concussion or mild traumatic brain injury – GCS 13–15 – is an increasingly common occurrence in the elderly. As with more severe TBI, falls are the most common mechanism.
Stryke et al. found that in these patients the rate of intracranial hemorrhage was three times higher than in younger adults [156].
The geriatric population presents special challenges in concussion assessment because there may be preexisting cognitive dysfunction, impaired memory, comorbid conditions, and use of multiple medications.
As a result the American College of Emergency Physicians recommends a head CT in any patient >65 who presents with a mechanism or findings suggestive of a concussion [157].
Outcome after a concussion is generally good; however, this may not be the case in elderly patients. Goldstein et al. (in patients >50 years old compared to controls) found a significant decrease in cognitive function, including language, memory, and executive function 7 months post concussion [158].
Additionally in a study of 3244 patients >64 years old, there was a higher incidence of non-survivors in the elderly population (risk ratio 7.8) [2].
Nevertheless there is a paucity of research on concussion in the elderly. Thus, more aggressive evaluation of post-concussive issues may be needed with earlier utilization of neuropsychological evaluations to more precisely identify and treat deficits in this patient population.
Spinal Cord Injury
Over the last several decades, the incidence of SCI in geriatric patients has increased from 4.2 to 15.4 % [159].
Similar to the brain there is a progressive loss of neuronal tissue in the spinal cord. One study showed up to a 46 % loss in those >50 years [160]. In spite of this loss, there is no apparent effect on spinal cord function, but with less reserve the spinal cord may be more vulnerable to the effects of aging of the vertebral column such as spondylosis.
Also similar to TBI, falls account for the majority of geriatric SCI.
In comparison with younger patients, geriatric SCI patients appear to be less likely to suffer severe SCI; however, they have a higher mortality rate [161].
One study found that older patients with SCI are less likely to undergo surgery for their spinal injury, and when they do there is a significant delay between the injury and any subsequent surgery [161]. This may be related to coexisting medical comorbidities or treatment bias due to advanced age.
Palliative Care
Discussions of palliative care in trauma patients are becoming increasingly common. In elderly patients with severe TBI or SCI the issue takes on even more importance. While an advanced directive may exist, such is difficult to access in an emergency situation, in a comatose patient whose family may very well not be immediately available. Thus operative decisions are often left to the surgeon. Unfortunately assuming advanced age is always associated with death is not supported in the literature.
The American College of Surgeons Optimal Resources Manual defines an ideal trauma system as one that includes “all the components identified with optimal trauma care, such as prevention, access, acute hospital care, rehabilitation and research activities.” There is no mention of palliative care [162].
Several studies have shown that those >55 are more likely to suffer multiple organ failure and even seemingly mildly injured patients >60 have a fivefold greater risk of dying [163, 164].
A high likelihood of death is not the only factor in considering palliative care over surgery or other aggressive treatments. The patient’s subsequent quality of life and likely functional outcome should play a role in making this decision.
Thus, in an “optimal” trauma system, it is important to integrate palliative care concepts in all members of the trauma team [165].
References
1.
Ramanathon DM, McWilliams V, Schatz T, et al. Epidemiological shifts in elderly TBI:18 year trends in Pennsylvania. J Neurotrauma. 2012;29:1371–8.
2.
Susman M, DiRusso SM, Sullivan T, Risucci D, Nealon P, Cuff S, Haider A, Benzil D. Traumatic brain injury in the elderly: increased mortality and worse functional outcome at discharge despite lower injury severity. J Trauma. 2002;53(2):219–23; discussion 223–14.
3.
Tokutomi T, Miyagi T, Ogawa T, Ono J, Kawamata T, Sakamoto T, Shigemori M, Nakamura N. Age-associated increases in poor outcomes after traumatic brain injury: a report from the Japan Neurotrauma Data Bank. J Neurotrauma. 2008;25(12):1407–14.PubMed
4.
Stocchetti N, Paterno R, Citerio G, Beretta L, Colombo A. Traumatic brain injury in an aging population. J Neurotrauma. 2012;29(6):1119–25.PubMed
5.
Hukkelhoven CW, Steyerberg EW, Rampen AJ, Farace E, Habbema JD, Marshall LF, Murray GD, Maas AI. Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patients. J Neurosurg. 2003;99(4):666–73.PubMed
6.
Mushkudiani NA, Engel DC, Steyerberg EW, Butcher I, Lu J, Marmarou A, Slieker F, McHugh GS, Murray GD, Maas AI. Prognostic value of demographic characteristics in traumatic brain injury: results from the IMPACT study. J Neurotrauma. 2007;24(2):259–69.PubMed
7.
Thompson HJ, McCormick WC, Kagan SH. Traumatic brain injury in older adults: epidemiology, outcomes, and future implications. J Am Geriatr Soc. 2006;54(10):1590–5.PubMedPubMedCentral
8.
Mosenthal AC, Lavery RF, Addis M, Kaul S, Ross S, Marburger R, Deitch EA, Livingston DH. Isolated traumatic brain injury: age is an independent predictor of mortality and early outcome. J Trauma. 2002;52(5):907–11.PubMed
9.
Munro PT, Smith RD, Parke TR. Effect of patients’ age on management of acute intracranial haematoma: prospective national study. BMJ. 2002;325(7371):1001.PubMedPubMedCentral
10.
Mohindra S, Mukherjee KK, Gupta R, Chhabra R. Continuation of poor surgical outcome after elderly brain injury. Surg Neurol. 2008;69(5):474–7.PubMed
11.
Bruns Jr J, Hauser WA. The epidemiology of traumatic brain injury: a review. Epilepsia. 2003;44(Suppl 10):2–10.PubMed
12.
Rothweiler B, Temkin NR, Dikmen SS. Aging effect on psychosocial outcome in traumatic brain injury. Arch Phys Med Rehabil. 1998;79(8):881–7.PubMed
13.
Richardson 3rd NS, Paysinger BD. Outcome of acute subdural and epidural hematomas in a level I trauma center in South Carolina. J S C Med Assoc. 1990;86(11):573–6.PubMed
14.
Pennings JL, Bachulis BL, Simons CT, Slazinski T. Survival after severe brain injury in the aged. Arch Surg. 1993;128(7):787–93; discussion 793–84.
15.
Flanagan SR, Hibbard MR, Riordan B, Gordon WA. Traumatic brain injury in the elderly: diagnostic and treatment challenges. Clin Geriatr Med. 2006;22(2):449–68. xPubMed